# A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

> **NCT00583609** · PHASE4 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 20 (estimated)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** PEG3350

## Key facts

- **NCT ID:** NCT00583609
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00583609

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00583609, "A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00583609. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*